![Xian Lin Li](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xian Lin Li
Président chez China National Pharmaceutical Industry Corp. Ltd.
Fortune : 29 397 $ au 30/06/2024
Profil
Xian Lin Li currently works as a Chairman & Manager at China National Pharmaceutical Industry Corp.
Ltd.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
14/04/2023 | 20 000 ( 0,00% ) | 29 397 $ | 30/06/2024 |
Postes actifs de Xian Lin Li
Sociétés | Poste | Début |
---|---|---|
China National Pharmaceutical Industry Corp. Ltd.
![]() China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Président | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
China National Pharmaceutical Industry Corp. Ltd.
![]() China National Pharmaceutical Industry Corp. Ltd. Pharmaceuticals: MajorHealth Technology China National Pharmaceutical Industry Corp. Ltd. engages in the narcotic pharmaceutical production. Its dosage includes injections, oral liquid, and freeze-dried powder. Its business scope covers research and development, and the whole process of narcotic drugs and psychotropic drugs' raw materials and preparations. Its products includes cardiovascular and cerebrovascular, analgesic drugs, other drugs, and cough medicine category. The company was founded in 1991 and is headquartered in Beijing, China. | Health Technology |